Fidelity Investments’s Precigen PGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.7M | Buy |
2,570,183
+571,587
| +29% | +$2.47M | ﹤0.01% | 1982 |
|
|
2026
Q1 | $7.73M | Sell |
1,998,596
-2,653,583
| -57% | -$10.9M | ﹤0.01% | 2135 |
|
|
2025
Q4 | $19.4M | Buy |
4,652,179
+4,535,517
| +3,888% | +$17.5M | ﹤0.01% | 1786 |
|
|
2025
Q3 | $384K | Sell |
116,662
-217,579
| -65% | -$614K | ﹤0.01% | 3134 |
|
|
2025
Q2 | $475K | Buy |
334,241
+17,100
| +5% | +$24.3K | ﹤0.01% | 2974 |
|
|
2025
Q1 | $473K | Sell |
317,141
-61,422
| -16% | -$96.7K | ﹤0.01% | 2922 |
|
|
2024
Q4 | $424K | Buy |
378,563
+33,359
| +10% | +$28.5K | ﹤0.01% | 2994 |
|
|
2024
Q3 | $327K | Buy |
345,204
+72,033
| +26% | +$90.9K | ﹤0.01% | 3022 |
|
|
2024
Q2 | $432K | Buy |
273,171
+17,536
| +7% | +$25.5K | ﹤0.01% | 2784 |
|
|
2024
Q1 | $371K | Sell |
255,635
-281
| -0.1% | -$404 | ﹤0.01% | 2825 |
|
|
2023
Q4 | $343K | Sell |
255,916
-57,449
| -18% | -$67.5K | ﹤0.01% | 2785 |
|
|
2023
Q3 | $445K | Buy |
313,365
+111,864
| +56% | +$159K | ﹤0.01% | 2653 |
|
|
2023
Q2 | $232K | Buy |
201,501
+2,113
| +1% | +$2.49K | ﹤0.01% | 2903 |
|
|
2023
Q1 | $211K | Buy |
199,388
+16
| +0% | +$23 | ﹤0.01% | 2951 |
|
|
2022
Q4 | $303K | Sell |
199,372
-1,988
| -1% | -$3.42K | ﹤0.01% | 2878 |
|
|
2022
Q3 | $427K | Buy |
201,360
+2,724
| +1% | +$5.74K | ﹤0.01% | 2824 |
|
|
2022
Q2 | $266K | Sell |
198,636
-3,171
| -2% | -$4.7K | ﹤0.01% | 3047 |
|
|
2022
Q1 | $426K | Buy |
201,807
+199,895
| +10,455% | +$487K | ﹤0.01% | 3035 |
|
|
2021
Q4 | $7K | Sell |
1,912
-9
| -0.5% | -$39 | ﹤0.01% | 3727 |
|
|
2021
Q3 | $10K | Buy |
1,921
+57
| +3% | +$328 | ﹤0.01% | 3619 |
|
|
2021
Q2 | $12K | Buy |
+1,864
| New | +$13K | ﹤0.01% | 3510 |
|
|
2020
Q3 | – | Sell |
-200
| Closed | -$1K | – | 3915 |
|
|
2020
Q2 | $1K | Buy |
+200
| New | +$680 | ﹤0.01% | 3490 |
|
|
2019
Q4 | – | Sell |
-29
| Closed | – | – | 4152 |
|
|
2019
Q3 | $0 | Buy |
+29
| New | +$197 | ﹤0.01% | 4125 |
|
|
2018
Q4 | – | Sell |
-4,783,389
| Closed | -$82.4M | – | 3980 |
|
|
2018
Q3 | $82.4M | Sell |
4,783,389
-200,688
| -4% | -$2.98M | 0.01% | 1032 |
|
|
2018
Q2 | $69.5M | Sell |
4,984,077
-297,575
| -6% | -$5.03M | 0.01% | 1114 |
|
|
2018
Q1 | $81M | Buy |
5,281,652
+1,505,351
| +40% | +$21.5M | 0.01% | 1071 |
|
|
2017
Q4 | $43.5M | Sell |
3,776,301
-1,815,094
| -32% | -$27M | 0.01% | 1362 |
|
|
2017
Q3 | $106M | Sell |
5,591,395
-6,118
| -0.1% | -$126K | 0.01% | 944 |
|
|
2017
Q2 | $135M | Sell |
5,597,513
-384,889
| -6% | -$8.44M | 0.02% | 840 |
|
|
2017
Q1 | $119M | Sell |
5,982,402
-534,706
| -8% | -$11.9M | 0.02% | 918 |
|
|
2016
Q4 | $157M | Sell |
6,517,108
-479,779
| -7% | -$13.4M | 0.02% | 785 |
|
|
2016
Q3 | $194M | Sell |
6,996,887
-119,163
| -2% | -$3.15M | 0.03% | 679 |
|
|
2016
Q2 | $174M | Sell |
7,116,050
-191,105
| -3% | -$5.42M | 0.02% | 729 |
|
|
2016
Q1 | $245M | Sell |
7,307,155
-575,332
| -7% | -$18.1M | 0.03% | 555 |
|
|
2015
Q4 | $236M | Sell |
7,882,487
-36,352
| -0.5% | -$1.23M | 0.03% | 593 |
|
|
2015
Q3 | $250M | Buy |
7,918,839
+5,239,330
| +196% | +$256M | 0.04% | 530 |
|
|
2015
Q2 | $130M | Sell |
2,679,509
-647,553
| -19% | -$27.3M | 0.02% | 911 |
|
|
2015
Q1 | $144M | Buy |
3,327,062
+1,266,314
| +61% | +$45.5M | 0.02% | 858 |
|
|
2014
Q4 | $54.2M | Sell |
2,060,748
-11,300
| -0.5% | -$248K | 0.01% | 1293 |
|
|
2014
Q3 | $36.8M | Sell |
2,072,048
-1,053,448
| -34% | -$21.5M | 0.01% | 1450 |
|
|
2014
Q2 | $75.1M | Sell |
3,125,496
-155,334
| -5% | -$3.15M | 0.01% | 1153 |
|
|
2014
Q1 | $82.4M | Buy |
3,280,830
+923,929
| +39% | +$25.6M | 0.01% | 1083 |
|
|
2013
Q4 | $53.6M | Buy |
2,356,901
+193,781
| +9% | +$3.92M | 0.01% | 1282 |
|
|
2013
Q3 | $49M | Buy |
+2,163,120
| New | +$49.9M | 0.01% | 1290 |
|
Other funds holding PGEN
PCM
DC
TCM
BCM
IAM
Fidelity Investments's PGEN Position: Q2 2026 in Review
Fidelity Investments increased its Precigen (PGEN) stake by 29% in Q2 2026, buying an estimated $2.47M and bringing the position to 2,570,183 shares worth $14.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1982.
Fidelity Investments first reported a position in PGEN in Q3 2013 and has held it in 44 quarters since. The position peaked at $250M in Q3 2015. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.
- Fidelity Investments held 2,570,183 shares of Precigen worth $14.7M as of Q2 2026.
- Fidelity Investments bought 571,587 Precigen shares in Q2 2026, an estimated $2.47M.
- Precigen made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1982 holding.
- Fidelity Investments first reported a position in Precigen in Q3 2013 and has held it in 44 quarters since.
- Fidelity Investments's Precigen position peaked at $250M in Q3 2015.
- 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.